| |
| | Andrew M. Davidoff, MD (Site not responding. Last check: 2007-11-04) |
 | | Vectors expressing a number of different angiogenesis inhibitors are currently being designed and tested in vitro and in vivo in murine models of neuroblastoma. |
 | | Increased plasma vascular endothelial growth factor (VEGF) as a surrogate marker for optimal therapeutic dosing of VEGF receptor-2 monoclonal antibodies. |
 | | Davidoff AM, Hebra A, Balmer D, Templeton JM, Jr., Schnaufer L. Management of the gastrointestinal tract and nutrition in patients with cloacal exstrophy. |
| www.stjude.org /faculty/0,2512,407_2030_4099,00.html (959 words) |
|